PDX1, Neurogenin-3, and MAFA: Critical Transcription Regulators for Beta Cell Development and Regeneration

Overview

Journal Stem Cell Res Ther

Publisher Biomed Central

Date 2017 Nov 4

PMID 29096722

Citations 135

Authors

Yaxi Zhu

Qian Liu

Zhiguang Zhou

Yasuhiro Ikeda

Affiliations

Soon will be listed here.

Abstract

Transcription factors regulate gene expression through binding to specific enhancer sequences. Pancreas/duodenum homeobox protein 1 (PDX1), Neurogenin-3 (NEUROG3), and V-maf musculoaponeurotic fibrosarcoma oncogene homolog A (MAFA) are transcription factors critical for beta cell development and maturation. NEUROG3 is expressed in endocrine progenitor cells and controls islet differentiation and regeneration. PDX1 is essential for the development of pancreatic exocrine and endocrine cells including beta cells. PDX1 also binds to the regulatory elements and increases insulin gene transcription. Likewise, MAFA binds to the enhancer/promoter region of the insulin gene and drives insulin expression in response to glucose. In addition to those natural roles in beta cell development and maturation, ectopic expression of PDX1, NEUROG3, and/or MAFA has been successfully used to reprogram various cell types into insulin-producing cells in vitro and in vivo, such as pancreatic exocrine cells, hepatocytes, and pluripotent stem cells. Here, we review biological properties of PDX1, NEUROG3, and MAFA, and their applications and limitations for beta cell regenerative approaches. The primary source literature for this review was acquired using a PubMed search for articles published between 1990 and 2017. Search terms include diabetes, insulin, trans-differentiation, stem cells, and regenerative medicine.

Citing Articles

Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status.

Hu C, Chen Y, Yin X, Xu R, Yin C, Wang C Signal Transduct Target Ther. 2025; 10(1):39.

PMID: 39948335 PMC: 11825823. DOI: 10.1038/s41392-024-02098-3.

Recent advances in pancreatic α-cell transdifferentiation for diabetes therapy.

Li Y, Zhu J, Yue C, Song S, Tian L, Wang Y Front Immunol. 2025; 16:1551372.

PMID: 39911402 PMC: 11794509. DOI: 10.3389/fimmu.2025.1551372.

Research progress of GLP-1RAs in the treatment of type 2 diabetes mellitus.

He X, Zhao W, Li P, Zhang Y, Li G, Su H Front Pharmacol. 2025; 15:1483792.

PMID: 39902077 PMC: 11788294. DOI: 10.3389/fphar.2024.1483792.

Epigenetic memory as crucial contributing factor in directing the differentiation of human iPSC into pancreatic β-cells in vitro.

Diane A, Mu-U-Min R, Al-Siddiqi H Cell Tissue Res. 2025; 399(3):267-276.

PMID: 39883142 PMC: 11870940. DOI: 10.1007/s00441-025-03952-8.

Spint1 disruption in mouse pancreas leads to glucose intolerance and impaired insulin production involving HEPSIN/MAFA.

Lin H, Yu I, Cheng M, Chang T, Lin H, Chang Y Nat Commun. 2024; 15(1):10537.

PMID: 39627229 PMC: 11615295. DOI: 10.1038/s41467-024-54927-2.

References

Noso S, Kataoka K, Kawabata Y, Babaya N, Hiromine Y, Yamaji K . Insulin transactivator MafA regulates intrathymic expression of insulin and affects susceptibility to type 1 diabetes. Diabetes. 2010; 59(10):2579-87. PMC: 3279543. DOI: 10.2337/db10-0476. View

Conrad E, Stein R, Hunter C . Revealing transcription factors during human pancreatic β cell development. Trends Endocrinol Metab. 2014; 25(8):407-14. PMC: 4167784. DOI: 10.1016/j.tem.2014.03.013. View

Li W, Nakanishi M, Zumsteg A, Shear M, Wright C, Melton D . In vivo reprogramming of pancreatic acinar cells to three islet endocrine subtypes. Elife. 2014; 3:e01846. PMC: 3977343. DOI: 10.7554/eLife.01846. View

Holland A, Hale M, Kagami H, Hammer R, MacDonald R . Experimental control of pancreatic development and maintenance. Proc Natl Acad Sci U S A. 2002; 99(19):12236-41. PMC: 129428. DOI: 10.1073/pnas.192255099. View

Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton D . In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature. 2008; 455(7213):627-32. PMC: 9011918. DOI: 10.1038/nature07314. View

Xu H, Tsang K, Chan J, Yuan P, Fan R, Kaneto H . The combined expression of Pdx1 and MafA with either Ngn3 or NeuroD improves the differentiation efficiency of mouse embryonic stem cells into insulin-producing cells. Cell Transplant. 2012; 22(1):147-58. DOI: 10.3727/096368912X653057. View

Churchill A, Dominguez Gutierrez G, Singer R, Lorberbaum D, Fischer K, Sussel L . Genetic evidence that Nkx2.2 acts primarily downstream of Neurog3 in pancreatic endocrine lineage development. Elife. 2017; 6. PMC: 5224921. DOI: 10.7554/eLife.20010. View

Talchai C, Xuan S, Lin H, Sussel L, Accili D . Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure. Cell. 2012; 150(6):1223-34. PMC: 3445031. DOI: 10.1016/j.cell.2012.07.029. View

Akinci E, Banga A, Tungatt K, Segal J, Eberhard D, Dutton J . Reprogramming of various cell types to a beta-like state by Pdx1, Ngn3 and MafA. PLoS One. 2013; 8(11):e82424. PMC: 3843737. DOI: 10.1371/journal.pone.0082424. View

10.

Yechoor V, Liu V, Espiritu C, Paul A, Oka K, Kojima H . Neurogenin3 is sufficient for transdetermination of hepatic progenitor cells into neo-islets in vivo but not transdifferentiation of hepatocytes. Dev Cell. 2009; 16(3):358-73. PMC: 2676438. DOI: 10.1016/j.devcel.2009.01.012. View

11.

Valdez I, Dirice E, Gupta M, Shirakawa J, Teo A, Kulkarni R . Proinflammatory Cytokines Induce Endocrine Differentiation in Pancreatic Ductal Cells via STAT3-Dependent NGN3 Activation. Cell Rep. 2016; 15(3):460-470. PMC: 4838491. DOI: 10.1016/j.celrep.2016.03.036. View

12.

Gradwohl G, Dierich A, Lemeur M, Guillemot F . neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci U S A. 2000; 97(4):1607-11. PMC: 26482. DOI: 10.1073/pnas.97.4.1607. View

13.

Wang S, Yan J, Anderson D, Xu Y, Kanal M, Cao Z . Neurog3 gene dosage regulates allocation of endocrine and exocrine cell fates in the developing mouse pancreas. Dev Biol. 2009; 339(1):26-37. PMC: 2824035. DOI: 10.1016/j.ydbio.2009.12.009. View

14.

Cim A, Sawyer G, Zhang X, Su H, Collins L, Jones P . In vivo studies on non-viral transdifferentiation of liver cells towards pancreatic β cells. J Endocrinol. 2012; 214(3):277-88. DOI: 10.1530/JOE-12-0033. View

15.

Nostro M, Sarangi F, Ogawa S, Holtzinger A, Corneo B, Li X . Stage-specific signaling through TGFβ family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells. Development. 2011; 138(5):861-71. PMC: 3035090. DOI: 10.1242/dev.055236. View

16.

Rezania A, Bruin J, Arora P, Rubin A, Batushansky I, Asadi A . Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nat Biotechnol. 2014; 32(11):1121-33. DOI: 10.1038/nbt.3033. View

17.

Oliver-Krasinski J, Kasner M, Yang J, Crutchlow M, Rustgi A, Kaestner K . The diabetes gene Pdx1 regulates the transcriptional network of pancreatic endocrine progenitor cells in mice. J Clin Invest. 2009; 119(7):1888-98. PMC: 2701861. DOI: 10.1172/JCI37028. View

18.

Chen Y, Finkbeiner S, Weinblatt D, Emmett M, Tameire F, Yousefi M . De novo formation of insulin-producing "neo-β cell islets" from intestinal crypts. Cell Rep. 2014; 6(6):1046-1058. PMC: 4245054. DOI: 10.1016/j.celrep.2014.02.013. View

19.

Glick E, Leshkowitz D, Walker M . Transcription factor BETA2 acts cooperatively with E2A and PDX1 to activate the insulin gene promoter. J Biol Chem. 2000; 275(3):2199-204. DOI: 10.1074/jbc.275.3.2199. View

20.

Raum J, Gerrish K, Artner I, Henderson E, Guo M, Sussel L . FoxA2, Nkx2.2, and PDX-1 regulate islet beta-cell-specific mafA expression through conserved sequences located between base pairs -8118 and -7750 upstream from the transcription start site. Mol Cell Biol. 2006; 26(15):5735-43. PMC: 1592775. DOI: 10.1128/MCB.00249-06. View